Vertero Therapeutics
PrivateLast Round
Series D
Oct 21, 2025
Total Funding Raised
$111.84M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vertero Therapeutics is a biotechnology company that develops oral small-molecule therapeutics targeting peripheral nervous system drivers of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vertero Therapeutics Comparables
Compare Vertero Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Piton Therapeutics | 86% | |
| Enterin | 82% | |
| Kallyope | 80% |
Vertero Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 21, 2025 | ||||
| Grant | Jun 20, 2023 | ||||
| Series C | Oct 13, 2021 | ||||
| Grant | Jul 28, 2020 | ||||
| Series B Extension | Jun 20, 2019 | ||||
Series B | Feb 27, 2019 |
Key People
Founding team and executive leadership
Vertero Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneVentures | Series D, Series C |
| Domain Associates | Series B, Series C, Series D, Series A |
| Kairos Ventures | Series A |
| Taiho Ventures | Series C, Series D, Series B Extension |
| Kairos Ventures | Series A |
| Corundum Systems Biology | Series C |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 1556% MoM.
- Oct 21, 2025
$20M round led by OneVentures and Seventure Partners.
Vertero Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vertero Therapeutics's valuation, stock price, and market status.
Is Axial Therapeutics a public or private company?
Axial Therapeutics is a private company.
What is the current stock price of Axial Therapeutics?
Axial Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Axial Therapeutics worth (valuation)?
Valuation information for Axial Therapeutics is not publicly available.
Can I buy Axial Therapeutics stock?
Axial Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Axial Therapeutics's last funding round?
Axial Therapeutics's most recent funding round was Series D on October 21, 2025.
Who are the main investors in Axial Therapeutics?
Key investors in Axial Therapeutics include OneVentures, Domain Associates, Taiho Ventures, Longwood Fund, Seventure Partners.
Will Axial Therapeutics IPO soon?
No public IPO plans have been announced for Axial Therapeutics.
How can I track Axial Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axial Therapeutics's secondary market activity and sign up for updates.